Longeveron Inc., 2026-03-25
An SEC Form D private-offering notice from Miami, FL, a $33,515,000 filer-stated offering target in Biotech. Filed 2026-03-25. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing laromestrocel (Lomecel-B), a stem cell therapy for cardiac, Alzheimer's, and aging-related conditions; Nasdaq-listed as LGVN.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Precision Aerospace & Defense Group, Inc., 2026-03-27, $1.5M, Aventura, FL
- Jabez Biosciences, Inc., 2026-03-26, Cranberry Twp., PA
- Circula-AI Inc, 2026-03-26, $2.1M, Boca Raton, FL
- 3X Genetics Inc., 2026-03-25, $4M, Worcester, MA
- Edgemode, Inc., 2026-03-26, $1M, Ft. Lauderdale, FL
- AN2 Therapeutics, Inc., 2026-03-25, $40M, Menlo Park, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.